Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PTEN is a dual-specificity phosphatase that acts as a tumor suppressor by antagonizing the PI3K/AKT/mTOR signaling pathway. It dephosphorylates PIP3, a key signaling molecule, and certain proteins, regulating cell growth, survival, and metabolism. Loss-of-function mutations in PTEN are frequently observed in various cancers and developmental disorders.
Dephosphorylates PIP3 to PI(4,5)P2, inhibiting PI3K/AKT/mTOR signaling. Acts as a protein phosphatase on substrates like FAK.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN (PTEN).